MEDICINOVA, INC. Recognition of Deferred Revenue
MEDICINOVA, INC. (MNOV) reported Recognition of Deferred Revenue of -$1.73 million for the 144-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2012-11-08
- MEDICINOVA, INC. recognition of deferred revenue for the quarter ending 2012-09-30 was $83.79K.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month | Recognition of Deferred Revenue 141 month | Recognition of Deferred Revenue 144 month |
|---|---|---|---|---|---|
| 2012-09-30 | $83.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $768.58K 10-Q · filed 2012-11-08 | -$1.73M 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $684.80K 10-Q · filed 2012-08-09 | -$1.82M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |